A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers

BACKGROUND: COVID-19 vaccination is one of the pivotal key tools against the ongoing pandemic, but its acceptance relies on efficacy and safety data among various populations, including patients with cancers. However, there is limited data on seroconversion rates, efficacy, and safety of the COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Haoran, Sahu, Kamal Kant, Kumar, Shruti Adidam, Nordblad, Blake, Sayegh, Nicolas, Tripathi, Nishita, Thomas, Vinay Mathew, Gupta, Sumati, Maughan, Benjamin L., Agarwal, Neeraj, Swami, Umang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467920/
https://www.ncbi.nlm.nih.gov/pubmed/36120495
http://dx.doi.org/10.1016/j.heliyon.2022.e10583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467920/
https://www.ncbi.nlm.nih.gov/pubmed/36120495
http://dx.doi.org/10.1016/j.heliyon.2022.e10583

Ejemplares similares